Image 1
Amoxapine Tablet
Product Images NDC 0591-5713
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amoxapine (NDC 0591-5713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Amoxapine is a medication available in the form of tablets, that contains 25 mg of USP Amoxapine. It is important that a pharmacist dispenses the medication along with a guide for each patient. The package insert contains the full prescribing information along with the dosage. The medicine should be kept in a tight container with child-resistant closure, and stored at a controlled room temperature between 20° to 25°C. The manufacturer is Watson Pharma Private Limited, located in Salcette Goa, India, and the distributor is Actavis Pharma Inc. The code and revision are GO/DRUGS/741 rev.02/15.*
Image 3
Amoxapine is a medication that comes in the form of tablets. Each tablet comprises 50 mg of Amoxapine, USP. The tablets are to be dispensed in a tight container with a child-resistant dosage. The pharmacies must provide the patient with a medication guide separately. The package insert should be referred to for the prescription's dosage and complete product information. The medication needs to be stored between 20°C to 25°C (68°F to 77°F) at controlled room temperature.
The packaging company is Watson Pharma Private Limited based in Verna, Salcette Goa in India. Actavis Pharma, Inc in Parsippany, NJ, the USA, distributes it. Lot number 190826-1 has been revised in Feb 2015 (Rev. 02/15).*
Image 4
Image 5
The text describes a medication guide for Amoxapine tablets, USP with a dosage of 150 mg. It is recommended to store it in a tight container with child-resistant closure at 20°C to 25°C. The medication is manufactured by Watson Pharma Private Limited and distributed by Actavis Pharma Inc. It contains NDC0591-5716-30 and code no. GO/DRUGS 741.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
